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Ubiquitination and deubiquitination are crucial for
assembly and disassembly of signaling complexes.
LUBAC-generated linear (M1) ubiquitin is important
for signaling via various immune receptors. We
show here that the deubiquitinases CYLD and
A20, but not OTULIN, are recruited to the TNFR1-
and NOD2-associated signaling complexes (TNF-
RSC and NOD2-SC), at which they cooperate to
limit gene activation. Whereas CYLD recruitment
depends on its interaction with LUBAC, but not on
LUBAC’s M1-chain-forming capacity, A20 recruit-
ment requires this activity. Intriguingly, CYLD and
A20 exert opposing effects on M1 chain stability in
the TNF-RSC and NOD2-SC. While CYLD cleaves
M1 chains, and thereby sensitizes cells to TNF-
induced death, A20 binding to them prevents their
removal and, consequently, inhibits cell death.
Thus, CYLD and A20 cooperatively restrict gene
activation and regulate cell death via their respec-
tive activities on M1 chains. Hence, the interplay be-
tween LUBAC, M1-ubiquitin, CYLD, and A20 is
central for physiological signaling through innate
immune receptors.INTRODUCTION
Ubiquitin is an evolutionarily highly conserved small protein of 76
amino acids (8.6 kDa). Ubiquitination is a post-translational pro-
tein modification, carried out by three classes of enzymes,
namely the ubiquitin-activating- (E1), ubiquitin-conjugating-
(E2), and ubiquitin-ligating-enzymes (E3). The consecutive ac-
tivity of these enzymes leads to the attachment of ubiquitin via
its C terminus to a target protein (Hershko and Ciechanover,
1998). Ubiquitin itself can be ubiquitinated by attachment of2258 Cell Reports 13, 2258–2272, December 15, 2015 ª2015 The Authe incoming ubiquitin to either of seven different lysine (K) resi-
dues (K6, K11, K27, K29, K33, K48, K63) or the N-terminal methi-
onine (M1). Thus, depending on the linkage type(s) target
proteins can be decorated with ubiquitin chains that are diverse
in their compositions and exhibit different three-dimensional
conformations (Kulathu and Komander, 2012).
Whereas K48-ubiquitin linkages serve to signal for protein
degradation by the proteasome (Hershko and Ciechanover,
1998), non-degradative ubiquitin chains have emerged as
important regulators of signals emanating from diverse immune
receptors including TNFR1, NOD2, CD40, TLR2, TLR4, and
IL-1R. Upon stimulation by their respective ligands, compo-
nents within the primary receptor-associated signaling com-
plexes (SCs) are modified by addition of K63- and M1-linked
and, in certain cases, also other types of ubiquitin chains (Fiil
and Gyrd-Hansen, 2014; Iwai et al., 2014; Shimizu et al.,
2015; Zinngrebe et al., 2014). Formation of K63 chains is medi-
ated by various E3 ubiquitin ligases specific for individual SCs.
The linear ubiquitin chain assembly complex (LUBAC), consist-
ing of HOIL-1, SHARPIN, and the catalytically active subunit
HOIP, is the only currently known E3 capable of forming M1
chains de novo (Gerlach et al., 2011; Haas et al., 2009; Ikeda
et al., 2011; Kirisako et al., 2006; Tokunaga et al., 2011). In
all of the above signaling pathways, LUBAC has been deter-
mined to be responsible for M1 chain formation (Damgaard
et al., 2012; Emmerich et al., 2013; Gerlach et al., 2011; Rodg-
ers et al., 2014). K63 chains are recognized by the ubiquitin
binding domains of TAB2 or TAB3 (Kanayama et al., 2004;
Wang et al., 2001), resulting in recruitment of the TAK/TAB
complex as well as LUBAC (Haas et al., 2009; Wang et al.,
2001). LUBAC then enables efficient recruitment of NEMO
and, consequently, of the NEMO/IKKa/IKKb (NEMO/IKK) com-
plex (Haas et al., 2009). These two functional units then coop-
eratively trigger activation of the NF-kB and MAPK signaling
pathways (Walczak et al., 2012). Absence of LUBAC therefore
attenuates gene induction by the above receptors and causes
early embryonic lethality in mice due to aberrant TNFR1-
induced endothelial cell death. Importantly, this cell death is
due to increased formation of complex II of TNFR1 and notthors
caused by attenuated gene activation from the TNF-RSC (Pelt-
zer et al., 2014).
To signal at the physiological level in response to a given stim-
ulus, it is not only required that the corresponding SC forms, but
it also has to disassemble with the appropriate kinetics. Regu-
lated assembly and disassembly of ubiquitin chains within SCs
are essential to achieve this. The enzymes responsible for
removing ubiquitin moieties from target proteins and cleaving
polyubiquitin chains are deubiquitinases (DUBs). DUBs impli-
cated in the regulation of signaling by TNFR1 and other immune
receptors are CYLD, A20 (Harhaj and Dixit, 2012), and the M1-
specific DUB OTULIN, which was recently proposed to specif-
ically antagonize LUBAC at SCs, including in the context of the
TNF-RSC and the NOD2-SC (Fiil et al., 2013; Keusekotten
et al., 2013; Rivkin et al., 2013). While CYLD antagonizes K63
linkages in SCs (Trompouki et al., 2003; Wright et al., 2007), it
cleaves various linkages in vitro, albeit with preference for K63
and M1 linkages (Komander et al., 2008; Ritorto et al., 2014).
A20 is induced by NF-kB upon stimulation of various immune re-
ceptors and hydrolyzes K11, K63, and K48 but not M1 linkages
(Mevissen et al., 2013; Ritorto et al., 2014; Wertz et al., 2004).
A20 binds to both K63 and M1 linkages via its Zinc finger (ZnF)
domains 4 and 7, respectively (Bosanac et al., 2010; Tokunaga
et al., 2012; Verhelst et al., 2012). Deficiency in these DUBs re-
sults in distinct phenotypes. In mice, OTULIN deficiency is
embryonically lethal due to vascular defects (Rivkin et al.,
2013). CYLD deficiency causes cylindromatosis in humans, a
disease characterized by formation of benign tumors in the
skin of affected individuals (Bignell et al., 2000; Blake and
Toro, 2009; Zhang et al., 2004). Deficiency in A20, but interest-
ingly not inactivation of its DUB activity, causes early death in
mice due to severe inflammation, implying that A20 likely exerts
major functions independently from its DUB activity (Lee et al.,
2000; Lu et al., 2013). Recently, HOIPwas found to directly asso-
ciate with both CYLD and OTULIN in non-stimulated cells (Elliott
et al., 2014; Fiil et al., 2013; Schaeffer et al., 2014; Takiuchi et al.,
2014).
Here, we analyzed the interplay between LUBAC, M1-ubiqui-
tin, and the various before-mentioned DUBs in assembly and
disassembly of immune SCs and the functional impact this inter-
play has on the regulation of their signaling output.
RESULTS
CYLD, but Not OTULIN, Forms Part of the Native
TNF-RSC
As linear ubiquitination is crucial for various immune signaling
pathways (Gerlach et al., 2011; Haas et al., 2009), we aimed to
understand how it is regulated in SCs. To do so, we created
cell lines that are genetically deficient in HOIP, the M1-chain-
forming component of LUBAC, and re-expressed tandem affinity
purification (TAP)-tagged (23 Strep-tag II followed by a PreSci-
ssion cleavage site and 13Flag) HOIP in these cells (Figure S1A).
We first analyzed the unstimulated LUBAC obtained from these
cells by mass spectrometry following TAP. In line with recent re-
ports (Elliott et al., 2014; Fu et al., 2014; Rivkin et al., 2013;
Schaeffer et al., 2014; Takiuchi et al., 2014), our data showed
that prior to stimulation, both CYLD and OTULIN interactedCell Repwith HOIP (Figures S1B–S1D). We therefore deemed it likely
that LUBAC would mediate recruitment of both of these DUBs
to SCs. Unexpectedly, however, a kinetic analysis following tu-
mor necrosis factor (TNF) stimulation revealed that OTULIN
was not recruited to the TNF-RSC following TNF stimulation,
despite being present in lysates, whereas recruitment of CYLD
was evident, interestingly with kinetics reminiscent of LUBAC
recruitment (Figure 1A). Thus, CYLD forms part of the TNF-
RSC and OTULIN does not.
It is currently unclear how CYLD is recruited to SCs, including
the TNF-RSC, although Optineurin was previously suggested to
be involved (Nagabhushana et al., 2011). As CYLD interacts with
LUBAC prior to stimulation, and because it is recruited to the
TNF-RSC with similar kinetics as LUBAC, we wondered whether
recruitment of CYLD may require HOIP. Analyzing the native
TNF-RSC in HOIP-proficient versus -deficient cells revealed
that while CYLD was present in the TNF-RSC of HOIP-proficient
A549 (Figure 1B) and HaCaT (Figure S1E) cells, it was absent
from it in their HOIP-deficient counterparts (Figures 1B and
S1E). Thus, HOIP is required for recruitment of CYLD to the
TNF-RSC.
CYLDRecruitment to the TNF-RSCRequires LUBAC, but
Not M1-Ubiquitin
To determine whether absence of M1 chains from the TNF-
RSC affected CYLD presence and OTULIN absence, we
reconstituted HOIP-deficient cells with either TAP-tagged
wild-type (WT) or enzymatically inactive HOIP-C885S (Smit
et al., 2012; Stieglitz et al., 2012). When examining the effects
of absence of LUBAC activity on the constitutive interaction of
HOIP with CYLD and OTULIN, we found that neither of these
interactions required HOIP activity (Figure 1C). Regarding the
TNF-RSC, in line with our previous results, this complex is
less stable in the absence of HOIP or its activity (Haas et al.,
2009). Consequently, all proteins were retained less efficiently
in the complex (Figure 1D). Importantly, however, cells ex-
pressing HOIP-C885S maintained the capacity to recruit
CYLD to the TNF-RSC, yet OTULIN remained absent from
this complex (Figure 1D). We therefore conclude that the enzy-
matic activity of HOIP is not required for recruitment of CYLD
to the TNF-RSC.
CYLD, but Not OTULIN, Forms Part of the NOD2-SC and
Is Recruited via HOIP
As mentioned above, the mechanism of CYLD recruitment to
SCs is currently unclear. As CYLD interaction with LUBAC
was responsible for TNF-RSC recruitment, we wondered
whether LUBAC might also be responsible for recruitment of
CYLD to other SCs. To test this hypothesis, we analyzed the re-
ceptor-associated complex that forms upon stimulation of
NOD2 because, despite of being composed quite differently
from the TNF-RSC, signaling via NOD2 also involves LUBAC
(Damgaard et al., 2012; Fiil et al., 2013). NOD2 is an intracellular
pattern-recognition receptor (PRR) recognizing components of
the bacterial cell wall, and it plays a critical role in gastrointes-
tinal host defense (Chen et al., 2009). As previous studies em-
ployed a system triggered by overexpression of NOD2 that
does not require ligand-induced stimulation and to avoidorts 13, 2258–2272, December 15, 2015 ª2015 The Authors 2259
Figure 1. HOIP Is Required for Recruitment of CYLD to the TNF-RSC whereas OTULIN Is Not Recruited
(A) U937 cells were stimulated with TAP-TNF (1 mg/ml) for the indicated times. The TNF-RSC was immunoprecipitated via a-Flag beads and analyzed by
western blot.
(B) WT and HOIP-deficient A549 cells were stimulated with TAP-TNF (500 ng/ml) and subjected to immunoprecipitation as in (A).
(C) HOIP-deficient A549 cells were reconstituted with either HOIP-WT-TAP or HOIP-C885S-TAP or vector control. Cells were subsequently stimulated with TNF
(500 ng/ml) for 15 min or left untreated prior to LUBAC immunoprecipitation via a-Flag beads and analysis by western blot.
(D) The TNF-RSC isolated from HOIP-deficient A549 cells reconstituted with vector control, HOIP-WT, or catalytically dead HOIP-C885S was analyzed by
western blot.possible non-physiological events resulting from ligand-inde-
pendent signaling by NOD2 overexpression, we generated sta-
ble clones expressing TAP-tagged NOD2 at intermediate
levels. In these cells, NOD2-SC formation requires ligand-
induced stimulation, which more closely resembles the physio-
logical situation. Stimulation of these cells with synthetic
muramyl dipeptide (MDP) L18-MDP, a known ligand for
NOD2 (Grimes et al., 2012), induced strong NF-kB activation
in HOIP-proficient, but not in HOIP-deficient cells (Figures 2A
and S2A). In line with reports on HOIP’s requirement for Erk
activation upon CD40 and TNFR1 stimulation (Peltzer et al.,
2014; Sasaki et al., 2013), we found that activation of Erk
was also substantially inhibited in HOIP-deficient NOD2-stimu-
lated cells (Figure S2A). Thus, NOD2-induced phosphorylation
of ERK and IkB largely depends on LUBAC.2260 Cell Reports 13, 2258–2272, December 15, 2015 ª2015 The AuWe next analyzed the NOD2-SC and found that CYLD also
forms part of this complex (Figures 2B and S2B). As with the
TNF-RSC, HOIP is essential for recruitment of CYLD to the
NOD2-SC (Figures 2B and S2B), while OTULIN also does
not form part of this complex (Figure 2B). CYLD was previ-
ously described as an inhibitor of TNF signaling (Brummel-
kamp et al., 2003; Kovalenko et al., 2003). To evaluate the
role of CYLD in NOD2-mediated signaling, we isolated
bone-marrow derived macrophages (BMDMs) from WT and
CYLD-deficient mice and stimulated them with L18-MDP, as
these cells constitutively express NOD2. This revealed that
in the absence of CYLD, NOD2-induced gene activation via
NF-kB and MAPKs (Erk, p38, and JNK) is enhanced (Fig-
ure 2C). Thus, CYLD limits gene activation induced by the
NOD2-SC.thors
Figure 2. HOIP Recruits CYLD to the NOD2-SC
(A) A549 cells pro- or deficient in HOIP expression were stably transfected with NOD2-TAP, stimulated with L18-MDP (200 ng/ml) for the indicated times, and
analyzed by western blot.
(B) A549 cells pro- or deficient in HOIP were virally transfected with NOD2-TAP and stimulated with L18-MDP (200 ng/ml) for the indicated times. The NOD2-SC
was isolated by Flag-tag immunoprecipitation.
(C) Bone-marrow-derivedmacrophages (BMDMs) isolated frommice pro- or deficient in CYLDwere stimulated with L18-MDP (200 ng/ml) for the indicated times
and analyzed by western blot.Mutually Exclusive Binding of CYLD and OTULIN to HOIP
Causes CYLD-Selective Recruitment to SCs
As it was unclear why OTULIN could be absent from LUBAC-
containing SCs despite interacting with LUBAC in the cytosol
prior to stimulation, we next aimed to find a biochemical expla-
nation for this unexpected phenomenon. The crystal structure
of the HOIP PUB domain bound to the OTULIN PIM peptide
(aa 49–67) shows that Tyr56 in OTULIN and Asn102 in HOIP
are crucial for their interaction (Elliott et al., 2014; Schaeffer
et al., 2014). Accordingly, phosphorylation of anOTULIN-derived
peptide on the residue corresponding to Tyr56 prevented its as-
sociation with HOIP’s PUB domain (Elliott et al., 2014). There-
fore, one possible explanation of OTULIN’s absence from SCs
could be its release from LUBAC as a result of Tyr56 phosphor-
ylation. This event would have to be postulated to occur at, or
shortly following, recruitment. TNF stimulation, however, did
not abolish the interaction between HOIP and OTULIN (Figures
1C and S3A). Furthermore, induction of global tyrosine phos-
phorylation by pervanadate treatment, which induces irrevers-
ible inhibition of phosphatases, did not prevent this association
either (Figure 3A). Conversely, reduction of overall tyrosine phos-
phorylation by phosphatase treatment did not increase it (Fig-
ure 3A). Thus, stimulation-associated tyrosine phosphorylation
of OTULIN, including at Tyr56, cannot be responsible for
OTULIN’s absence from SCs.
Intriguingly, HOIP’s relatively small PUB domain mediates the
interaction with both CYLD and OTULIN and even short dele-
tions in this domain abolished interaction with both factors (Fig-
ures S3B–S3D). This suggested that steric hindrance may
prevent simultaneous interaction of HOIP with CYLD andCell RepOTULIN. If that was the case, they would compete for binding
to HOIP so that CYLD-interacting LUBAC would be devoid of
OTULIN and vice versa. To test this possibility, we precipitated
TAP-taggedOTULIN and checked for binding of LUBAC compo-
nents and CYLD. While LUBAC components were co-precipi-
tated, CYLD was not (Figure 3B). Thus, CYLD and TAP-tagged
OTULIN do not form part of the same individual LUBAC com-
plexes, implying that they indeed cannot simultaneously interact
with an individual HOIP protein. To address whether this also
holds true for endogenous OTULIN, we next quantitatively
immunoprecipitated OTULIN from WT cells, which would
result in removal of the fraction of LUBAC bound to endogenous
OTULIN, yet without co-precipitating CYLD. In accord with this
hypothesis, CYLD did not form part of endogenous OTULIN-
associated LUBAC complexes. Subsequent CYLD immunopre-
cipitation from OTULIN-depleted samples revealed that a
second fraction of LUBAC is bound to CYLD (Figure 3C). Hence,
there are two distinct fractions of LUBAC in the cell, one associ-
ated with CYLD, and another one bound to OTULIN.
The HOIP-OTULIN interaction can be disrupted bymutation of
a critical residue (N102) in HOIP’s PUB domain (Elliott et al.,
2014). To test whether the CYLD-HOIP interaction would also
be affected by this mutation, we reconstituted HOIP-deficient
cells with HOIP-N102A and checked for association with
CYLD. This revealed that HOIP-N102A was unable to bind to
CYLD (Figure 3D). Together, these results show that CYLD and
OTULIN interact with HOIP via the same or an overlapping site
and that HOIP’s interactions with CYLD and OTULIN are mutu-
ally exclusive. Based on these results, in combination with our
findings regarding the composition of the TNF-RSC (Figure 1)orts 13, 2258–2272, December 15, 2015 ª2015 The Authors 2261
Figure 3. Mutually Exclusive Binding of CYLD and OTULIN to HOIP Causes CYLD-Selective Recruitment to SCs
(A) A549 cells were incubated with pervanadate prior to lysis or left untreated. Indicated lysates were subjected to phosphatase treatment prior to OTULIN
immunoprecipitation.
(B) K562 cells expressing either HOIP-TAP, OTULIN-TAP, or vector control were subjected to a-Flag immunoprecipitation and analyzed by western blot.
(C) Lysate from A549 cells was subjected to immunoprecipitation for HOIP (IP: HOIP) or OTULIN (first IP: OTULIN). OTULIN-immuno-depleted lysate was
subsequently subjected to CYLD immunoprecipitation (second IP: CYLD).
(D) A549 cells deficient in HOIP and reconstituted with HOIP-WT, HOIP-N102A, or vector control were subjected to immunoprecipitation for HOIP or OTULIN and
subsequently analyzed by western blot.
(E) A549 cells deficient in HOIP and reconstituted with HOIP-WT, HOIP-N102A, or vector control were stimulated with TAP-TNF (500 ng/ml) for 15 min or left
untreated. The TNF-RSC was immunoprecipitated via a-Flag beads and analyzed by western blot.
(F) A549 cells deficient in HOIP and reconstituted with HOIP-WT, HOIP-N102A, or vector control were stimulated with TNF (500 ng/ml) for indicated times, and
lysates were analyzed by western blot.
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and the NOD2-SC (Figure 2), it can be concluded that CYLD-
associated LUBAC is recruited to SCs, whereas LUBAC associ-
ated with OTULIN is not.
Concomitant Loss of OTULIN and CYLD Interaction with
HOIP Increases M1 Ubiquitination at the TNF-RSC and
Enhances TNF-Induced Gene Activation
TNF stimulation induces expression of various response
genes, which help counteract invading pathogens but also pro-
mote autoinflammation (Walczak, 2011). We therefore analyzed
the TNF-RSC in cells expressing HOIP N102A to assess func-
tional consequences of the loss of DUB interaction with HOIP.
The recruitment of CYLD was abrogated in cells expressing
this HOIP variant (Figure 3E), confirming that the interaction
with LUBAC is required for CYLD recruitment. Following TNF
stimulation, these cells showed increased M1 ubiquitination
at the TNF-RSC (Figure 3E) and enhanced activation of NF-
kB (Figure 3F). Similar results were obtained with cells ex-
pressing HOIP devoid of the PUB domain (Figure S3E).
Furthermore, the lack of HOIP’s PUB domain resulted in
increased TNF-induced expression of IRF1, ICAM1, TNF, and
IkBa (Figure S3F). NEMO was previously shown to be linearly
ubiquitinated (Gerlach et al., 2011; Tokunaga et al., 2009),
and this polyubiquitination event, albeit weak, could be
observed in cells expressing HOIP-WT but not in cells lacking
HOIP or expressing inactive HOIP. In cells expressing HOIP-
N102A, however, the polyubiquitination of NEMO was
enhanced (Figure S3G). Thus, abolishing HOIP’s capacity to
interact with both CYLD and OTULIN enhances M1 ubiquitina-
tion in the TNF-RSC and, consequently, TNF-induced gene
activation.
OTULIN Deficiency Leads to Accumulation of M1 Chains
in the Cytosol but Not at the TNF-RSC or NOD2-SC
As HOIP-associated OTULIN was not recruited to SCs, we next
studied whether OTULIN deficiency may increase levels of linear
ubiquitin found in the cytosol. Using CRISPR-Cas9, we gener-
ated OTULIN-deficient cells. Already prior to stimulation, these
cells contained significantly more M1-linked ubiquitin chains in
their cytosol than control cells (Figures 4A and S4A). These aber-
rantM1 chains were not free chains but conjugated to substrates
(Figure S4B). The accumulation of linear ubiquitin linkages was
found to be due to absence of OTULIN’s enzymatic activity (Fig-
ure S4C). However, in accordance with our observation that
OTULIN is not present at the TNF-RSC, linear ubiquitination
within the TNF-RSC was not increased in OTULIN-KO as
compared to WT cells (Figures 4A and S4A). This was also the
case in the NOD2-SC (Figures 4B and S4D).
These circumstances led us to suspect that, instead of
antagonizing M1-ubiquitin at SCs, OTULIN might regulate
LUBAC components themselves. To identify which proteins
show increased linear ubiquitination in lysates of OTULIN-defi-
cient cells, we devised a new strategy to enrich for M1-ubiqui-
tinated proteins. This method, which we will refer to as
M1-affinity purification (M1-AP), employs a bead-resin-immobi-
lized, enzymatically inactive portion of OTULIN (aa 58–352,
C129A) that binds to, but does not cleave, M1 linkages with
high affinity and specificity (Keusekotten et al., 2013) (FiguresCell RepS4E and S4F). Prior to M1-AP, proteins were completely dena-
tured in 1% SDS and subsequently renatured so that only
proteins directly modified by ubiquitin chains containing M1
linkages, and not proteins that are only non-covalently associ-
ated with such chains, could be detected in these assays.
Notably, M1-AP showed that M1 ubiquitination of HOIL-1 and
SHARPIN was substantially increased in OTULIN-deficient cells
(Figure 4C). For technical reasons, we could not determine M1
ubiquitination of HOIP. In accord with the results of the TNF
immunoprecipitation, analysis of the components of the TNF-
RSC by M1-AP showed that M1 ubiquitination of RIP1, a known
LUBAC target in the TNF-RSC (Gerlach et al., 2011), was not
increased in OTULIN-deficient cells (Figure 4D). Hence, rather
than serving as a negative regulator of LUBAC activity at
SCs, OTULIN keeps components of LUBAC free of aberrant
M1 linkages prior to stimulation.
CYLD Antagonizes M1 Ubiquitination of TNF-RSC
Components
Since its association with LUBAC was the recruiting principle for
CYLD and because expression of HOIP-N102A, unable to recruit
CYLD to the TNF-RSC, increased the amount of M1 linkages in
this SC, we next sought to determine whether CYLD could be
responsible for antagonizing LUBAC activity in SCs. We em-
ployed CRISPR-Cas9 to create CYLD-deficient A549 cells and
stimulated them with TNF before subjecting them to M1-AP or
K63-AP, the latter being based on isolation of K63-ubiquitin link-
ages with tUIM (Sims et al., 2012) (Figure S5A). The absence of
CYLD increased overall TNF-inducedM1 andK63 ubiquitination.
When determining which proteins were modified by these link-
ages, we found that both M1 and K63 ubiquitination of RIP1,
TNFR1, and TRADDwere increased in the absence of CYLD (Fig-
ures 5A and S5B). This suggested that each one of these
proteins carries M1 and K63 chains when present in the TNF-
RSC, and that CYLD antagonizes both of them on all of these
proteins.
To determine whether TNFR1 and TRADD are bona fide
LUBAC targets, subsequent to TNF stimulation and isolation
by M1-AP we treated M1-ubiquitinated proteins with two
different recombinant DUBs (Figure S5C). Treatment with
OTULIN resulted in removal of all M1-linked chains from these
proteins (Figure 5B). Crucially, this treatment significantly
reduced the high-molecular-weight species of TNFR1, TRADD,
and RIP1 (Figure 5B). Thus, prior to OTULIN treatment M1-linked
ubiquitin chains had been present on these proteins. It should be
noted that complete removal of ubiquitin chains by OTULIN
would be expected only for exclusively linearly ubiquitinated tar-
gets. However, in line with our previous results regarding RIP1
(Gerlach et al., 2011), TRADD and TNFR1 also carry other chain
types, and the degree of reduction in their overall ubiquitination
by OTULIN treatment is indicative of the ratio between M1 link-
ages and other linkages present on these proteins. In contrast,
the DUB vOTU is capable of cleaving all ubiquitin linkages except
for the M1 linkage (Akutsu et al., 2011). Treatment with vOTU
resulted in removal of all linkages from M1-affinity purified
TNFR1, TRADD, and RIP1 (Figures 5B and S5D). As this includes
the ubiquitin moieties through which M1 chains are linked to
these proteins, a ladder of linear ubiquitin chains that are shedorts 13, 2258–2272, December 15, 2015 ª2015 The Authors 2263
Figure 4. OTULIN Constitutively Removes M1-Ubiquitin from LUBAC in Non-stimulated Cells
(A) The TNF-RSC was isolated from either WT or OTULIN-KO A549 cells stimulated with TAP-TNF (500 ng/ml) for the indicated times and subjected to
western blot.
(B) A549 cells pro- or deficient in OTULIN and virally transduced to express NOD2-TAP were stimulated with L18-MDP (200 ng/ml) for the indicated times. The
NOD2-SC was isolated by a-Flag immunoprecipitation.
(C and D) WT or OTULIN-deficient A549 cells were stimulated with TNF (200 ng/ml) for the indicated times. M1-ubiquitin-specific affinity purification (M1-AP) was
performed and samples were examined by western blot.from these proteins by vOTU treatment becomes apparent. As
they are completely hydrolyzed when OTULIN is added together
with vOTU, it can be concluded that these chains are pure M1-
linked chains (Figure 5B). Importantly, no linear ubiquitination
of RIP1, TNFR1, or TRADD was observed in cells lacking HOIP
(Figure S5D). These results identify TNFR1 and TRADD as previ-
ously unrecognized, additional bona fide targets of LUBAC in the
TNF-RSC. In addition, they show that the linear chains present
on these targets are of considerable length.
As absence of CYLD enhanced M1 ubiquitination of TNF-RSC
components, we assessed whether the recombinant USP
domain (aa 583–956) of CYLD (CYLD-USP), encompassing its
catalytic DUB activity, could be capable of removing ubiquitin
chains from them. Isolation of ubiquitinated proteins following2264 Cell Reports 13, 2258–2272, December 15, 2015 ª2015 The AuTNF stimulation and subsequent treatment with recombinant
CYLD-USP or vOTU showed that CYLD’s DUB domain is
capable of removing the majority of overall ubiquitination from
TNFR1, TRADD, and RIP1 (Figure 5C). The fact that treatment
with CYLD, in contrast to treatment with vOTU, did not release
M1 chains demonstrates that CYLD indeed hydrolyzes M1 link-
ages present on these target proteins (Figure 5C). Thus, CYLD
acts as a DUB that antagonizes both linear and K63 ubiquitin
linkages in the TNF-RSC.
CYLD Limits Gene Activation and Enhances Cell Death
in Response to TNF
As CYLD was previously described to be a positive regulator of
TNF-induced necroptosis (O’Donnell et al., 2011) and becausethors
(legend on next page)
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we previously showed that linear ubiquitination in the TNF-RSC
protects from TNF-induced cell death (Peltzer et al., 2014), we
next wanted to assess the impact of CYLD’s activity on M1
chains in the TNF-RSC in relation to TNF-induced cell death. In
line with previous studies, we found that CYLD-reconstituted
but not -deficient MEFs were prone to TNF- and TNF/zVAD-
induced cell death (Figure 5D). Importantly, this coincided with
a decrease in both linear ubiquitination of TNF-RSC components
and TNF-induced gene activation in CYLD-reconstituted MEFs
(Figures 5E and 5F). Thus, CYLD-mediated removal of ubiquitin
chains, including of linear chains, from components of the
TNF-RSC results in diminished TNF-induced gene activation
and, at the same time, enhanced cell death.
Recruitment of A20 to the TNF-RSC Requires LUBAC
and M1-Ubiquitin
Another major DUB involved in TNF signaling is A20. It is, how-
ever, debated how it is recruited to signaling complexes. The
ZnF4 domain of A20 selectively recognizes K63-linked ubiquitin,
andmutations in this domainwere reported to impair A20 recruit-
ment to the TNF-RSC (Bosanac et al., 2010; Lu et al., 2013).
Interestingly, the ZnF7 domain of A20 is involved in A20’s ability
to suppress NF-kB and cell death (Tokunaga et al., 2012; Ver-
helst et al., 2012). In addition, this domain binds with high affinity
to linear ubiquitin chains, and TNF-RSC recruitment of A20
devoid of ZnF7 is reduced (Tokunaga et al., 2012). This promp-
ted us to study the biochemical and functional interplay between
LUBAC, linear ubiquitination, and A20 in TNFR1 and NOD2
signaling.
A20 is induced by various stimuli in an NF-kB-dependent
manner (Catrysse et al., 2014). In all cell lines tested, we
observed, however, that A20 was already present before stimu-
lation. Consequently, it formed part of the TNF-RSC already
5 min after TNF stimulation, yet interestingly only in WT but not
HOIP-deficient cells (Figures 6A, S6A, and S6B). Prolonged stim-
ulation of up to 3 hr resulted in increased A20 expression and
recruitment to the TNF-RSC, again only in control and not in
HOIP-deficient cells (Figure S6C). A20 functions as a negative
regulator of NOD2 signaling (Hitotsumatsu et al., 2008). It was
unknown, however, whether it is recruited to the NOD2-SC.
We therefore next analyzed the NOD2-SC for A20 presence
and, if there, what the role of LUBAC would be in its recruitment.
This analysis revealed that A20 forms part of the NOD2-SC and
that HOIP is required for this (Figure 6B).
As LUBAC deficiency reduces gene activation, we next ad-
dressed the role of HOIP’s enzymatic activity in induction of
A20. As expected, HOIP-deficient cells showed substantiallyFigure 5. CYLD Removes M1- and K63-Ubiquitin from TNFR1, TRADD,
(A) WT or CYLD-deficient A549 cells were treatedwith TNF (200 ng/ml). M1-affinity
by western blot.
(B) U937 cells were stimulated with TNF (200 ng/ml). Samples were denatured an
vOTU, or both.
(C) Cells were treated as in (B), and samples were subjected to total ubiquitin-AP
(D–F) MEFs deficient in CYLDwere reconstitutedwith CYLD-WT or vector control.
of zVAD (20 mM), Nec-1 (10 mM), or both, and cell death was evaluated as percenta
*p < 0.05, **p < 0.0005, statistics were performed using t test) (D). Cells were stimu
isolated by a-Flag immunoprecipitation (E). Cells were stimulated with TNF (20
pathways was analyzed by western blot (F).
2266 Cell Reports 13, 2258–2272, December 15, 2015 ª2015 The Audecreased activation of NF-kB and, consequently, reduced pro-
duction of CCL2 and IL-8 as well as a comparably weak upregu-
lation of A20 upon TNF stimulation (Figures 6C–6E). In cells
expressing catalytically inactive HOIP-C885S the TNF-induced
stimulation of gene-activatory signaling pathways and cytokine
production was also decreased, yet not abolished (Figures 6C
and 6D). Interestingly, these cells had increased basal expres-
sion of A20 before stimulation, but 3 hr after stimulation the
A20 levels were almost identical to the ones observed in HOIP-
WT cells (Figure 6E). To evaluate whether the enzymatic activity
of HOIP is required for A20 recruitment to the TNF-RSC, we
therefore compared the TNF-RSC that forms after 3 hr in cells
expressing HOIP-WT and HOIP-C885S. This showed that
HOIP-C885S expressing cells are almost completely defective
in A20 recruitment to the TNF-RSC (Figure 6F). Together, this
identifies LUBAC-generated M1 chains as required for recruit-
ment of A20 to the TNF-RSC.
A20 Presence Stabilizes M1 and K63 Linkages in TNFR1
and NOD2 Complexes
Even though A20 is unable to cleave M1 linkages, we hypothe-
sized that it could affect M1 chains in SCs indirectly through
cleavage of other linkages. We therefore next assessed the
impact of A20 absence on the presence of linear ubiquitin chains
in the TNF-RSC. To do so, we again employed CRISPR-Cas9,
this time to generate A20-deficient A549 cells. Unexpectedly,
rather than being increased, M1 ubiquitination was markedly
decreased in the TNF-RSC of A20-deficient as compared to con-
trol cells, a finding that also applied to TNFR1 (Figure 7A). This
was confirmed using M1-AP (Figure S7A). A20 deficiency also
reduced the amount of M1-linked ubiquitin present in the
NOD2-SC (Figure 7B) and on RIP2 in this complex (Figure S7B).
Finally, alsoMEFs deficient in A20 showed amarked reduction in
linear ubiquitination at the TNF-RSC (Figure S7C). Together,
these results indicate that A20 presence stabilizes M1 linkages
in SCs.
Even though this result made it unlikely that A20’s DUB activity
was responsible for this effect, we could not formally exclude it
based on the experiments performed so far. Independently
thereof, we reasoned that because A20 is recruited to SCs via
linear ubiquitin chains, this interaction could be responsible for
their A20-endowed stabilization. Since A20’s ZnF7 was known
to bind M1 chains and to be required for TNF-RSC recruitment
(Tokunaga et al., 2012), we tested whether ZnF7 could be
responsible for A20-mediated stabilization of linear ubiquitin
chains at the TNF-RSC. To do so, we used CRISPR-Cas9 to pre-
pare cells lacking only the ZnF7 domain of A20 (Figure S7D). Inand RIP1
purification (AP) was performed, and the samples were subsequently analyzed
d subjected to M1-AP with subsequent treatment with recombinant OTULIN,
followed by treatment with recombinant CYLD (aa 583–956), vOTU, or both.
Cells were stimulated with TNF (200 ng/ml) for 24 hr in the presence or absence
ge of propidium iodide positive cells (data are presented asmean ±SEM [n = 3],
lated with TAP-TNF (500 ng/ml) for the indicated times, and the TNF-RSC was
0 ng/ml) for the indicated times, and activation of gene-activatory signaling
thors
Figure 6. Recruitment of A20 to the TNF-RSC Requires Linear Ubiquitination
(A) HOIP-pro- or deficient A549 cells were stimulated with TAP-TNF (500 ng/ml) for the indicated times and subjected to TNF-RSC isolation and western blot
analysis.
(B) A549 cells pro- or deficient in HOIP were transfected with NOD2-TAP and subsequently stimulated with L18-MDP (200 ng/ml). The NOD2-SC was immu-
noprecipitated via a-Flag beads and then analyzed by western blot.
(C–E) A549 cells deficient in HOIP were reconstituted with HOIP-WT, enzymatically inactive HOIP-C885S, or vector control. Cells were stimulated with TNF
(200 ng/ml) for the indicated times before analysis by western blot (C and E). Additionally, production of CCL2 and IL-8 was measured by ELISA after stimulation
with TNF (50 ng/ml) for 24 hr (data are presented as mean ± SEM [n = 3]) (D).
(F) HOIP-deficient A549 cells were reconstituted with HOIP-WT or enzymatically inactive HOIP-C885S. Samples were analyzed as in (A).line with previous results (Tokunaga et al., 2012), we found in
both A549 and HaCaT cells that absence of ZnF7 severely
compromised recruitment of A20 to the TNF-RSC and accumu-
lation of ubiquitin chains therein (Figures 7C and S7E). To assess
whether the DUB activity of A20 or its M1-binding function was
responsible for its capacity to stabilize M1 linkages in the TNF-
RSC, we reconstituted A20-deficient MEFs with A20-WT,
DUB-inactive A20 (A20-C103S), or an A20 ZnF7 point mutant
C779A/C782A (A20-ZnF7mut), which is unable to interact with
M1 chains (Tokunaga et al., 2012). Both A20-WT and A20-
C103S, but not A20-ZnF7mut, were recruited to the TNF-RSC
and stabilized linear ubiquitin linkages within this complex (Fig-
ures 7D and S7F). Thus, the linear-ubiquitin-binding activity ofCell RepA20, but not its DUB activity, is required for stabilization of linear
chains. In summary, these results show that direct binding of A20
to linear ubiquitin chains enables recruitment of A20 to the TNF-
RSC and that this, in turn, results in stabilization of M1-ubiquitin
chains in this complex.
The observation that ZnF7 is necessary for recruitment of
A20 to the TNF-RSC fits with the finding that A20-WT and
A20-C103S, but not A20-ZnF7mut, inhibit TNF-induced gene
activation (Figures 7E and S7G) and protect cells from TNF/
zVAD-induced necroptosis (Figure 7F) (Yamaguchi and Yama-
guchi, 2015). Hence, the activity of A20 as a binder and stabilizer
of linear ubiquitin linkages appears to be functionally more signif-
icant than its activity as a DUB.orts 13, 2258–2272, December 15, 2015 ª2015 The Authors 2267
DISCUSSION
OTULIN Antagonizes Basal LUBAC Activity, but Not M1-
Ubiquitin in SCs
Our analysis of LUBAC obtained from non-stimulated cells
confirmed previous reports that CYLD and OTULIN bind to the
PUB domain of HOIP (Takiuchi et al., 2014). To our surprise,
we found that, unlike CYLD, OTULIN formed part of neither the
native TNF-RSC nor the NOD2-SC. This contrasts with previous
reports addressing OTULIN recruitment to SCs. Fiil et al. (2013)
reported that transient overexpression of Flag-tagged NOD2 re-
sulted in its interaction with OTULIN. However, this system does
not require stimulation by a NOD2 ligand, and it is therefore
possible that the detected interaction could be a non-physiolog-
ical event related to NOD2 overexpression. In addition, Schaeffer
et al. (2014) proposed OTULIN to be recruited to the TNF-RSC.
Even though we were able to detect CYLD in two different
SCs, including the TNF-RSC, in all cell lines studied, we never
found OTULIN to be recruited. These results implied that SC re-
cruited HOIP was not associated with OTULIN, despite the fact
that OTULIN and HOIP interacted prior to stimulation. Indeed,
we found that OTULIN antagonizes LUBAC-mediated linear
ubiquitination in the cytoplasm but not at SCs. The function of
OTULIN is therefore likely to prevent accumulation of M1-ubiqui-
tin linkages outside of SCs (Figure 7G).
Aiming to find a mechanistic explanation for the unexpected
absence of OTULIN from SCs, we first turned our attention to
phosphorylation, as phosphorylation of OTULIN Tyr56 was pre-
viously reported to be capable of disrupting the interaction be-
tween HOIP and OTULIN (Elliott et al., 2014). Our data, however,
show that phosphorylation is not responsible for OTULIN
absence from SCs. The explanation was provided by our discov-
ery that HOIP cannot simultaneously bind OTULIN and CYLD as
both require HOIP-Asn102 for binding. We next demonstrated
the existence of two separate pools of cytoplasmic LUBAC:
one associated with OTULIN, the other one with CYLD. Impor-
tantly, whereas CYLD-bound LUBAC is recruited to the TNF-
RSC and the NOD2-SC, OTULIN-associated LUBAC is not. It
will be interesting to determine how OTULIN’s interaction with
HOIP prevents its recruitment to SCs, e.g., whether OTULIN
binding could interfere with HOIP’s ability to bind ubiquitin
chains, a requirement for LUBAC recruitment to SCs (Gerlach
et al., 2011; Haas et al., 2009).
CYLD Antagonizes LUBAC Activity in SCs
We show here that CYLD is recruited to SCs due to its interaction
with HOIP, independently of LUBAC’s enzymatic activity.
Furthermore, in cells expressing HOIP-N102A, which can
interact with neither CYLD nor OTULIN, CYLD is not recruited
to the TNF-RSC, demonstrating that CYLD’s interaction with
HOIP is essential for CYLD recruitment.
CYLD is a DUB with broad specificity, yet the enzymatically
active USP domain of CYLD, when produced recombinantly,
was previously shown to most efficiently hydrolyze M1- and
K63-linked tetra-ubiquitin in vitro (Komander et al., 2009). It
has been unclear to date, however, whether endogenous
CYLD would be able to regulate M1-ubiquitin, in addition to its
previously demonstrated role as a DUB that cleaves K63 link-2268 Cell Reports 13, 2258–2272, December 15, 2015 ª2015 The Auages on targets within the TNF-RSC (Brummelkamp et al.,
2003; Kovalenko et al., 2003; Trompouki et al., 2003; Wright
et al., 2007). Employing newly devised protocols for K63-AP
and M1-AP, we demonstrate here that, as a consequence of
CYLD deficiency, both K63- and M1-ubiquitin are increased on
several components of the TNF-RSC, including TNFR1, TRADD,
and RIP1. Furthermore, the recombinant USP domain of CYLD
completely removes M1 linkages, and indeed the majority of
other linkage types, from components of the TNF-RSC. Impor-
tantly, M1 linkages are fully hydrolyzed and not merely released
from complex components, as no free M1 chains appear
following treatment with CYLD. Collectively, these results iden-
tify CYLD as an antagonist of linear ubiquitination in SCs, in
addition to its previously described role as an antagonist of
K63-linked ubiquitination (Figure 7H).
Removal of M1-Ubiquitin from the TNF-RSC Accounts
for CYLD’s Pro-cell Death Role
We show that reconstitution of CYLD-deficient MEFs with CYLD,
but not with vector control, decreases M1-ubiquitin in the TNF-
RSC. This is accompanied by decreased gene activation, yet
interestingly, also with enhanced TNF-induced cell death. This
is in line with the fact that CYLD has previously been described
as being both an inhibitor of gene activation and promoter of
cell death, the latter by enhancing complex II formation upon
TNF stimulation (Hitomi et al., 2008; O’Donnell et al., 2011). We
previously showed that lack of linear ubiquitination in the TNF-
RSC enhances formation of complex II of TNF signaling (Peltzer
et al., 2014). Crucially, these experiments were performed with
HOIP-deficient cells. Based on the results presented here,
CYLD requires HOIP for TNF-RSC recruitment. Hence, in cells
lacking HOIP, CYLD does not form part of the TNF-RSC. Conse-
quently in these cells, CYLD cannot mediate the transition from
complex I of TNFR1 signaling (i.e., the TNF-RSC) to complex II.
Decisively, however, in HOIP-deficient cells this event does not
require CYLD activity; it readily occurs without it (Peltzer et al.,
2014). This identifies the lack of M1 chains in complex I as deci-
sive to render this complex unstable so that complex II can
readily form. Importantly, in this situation CYLD is not required
to enable this transition. We thus conclude that the M1-chain-
antagonizing activity of CYLD in complex I of TNFR1 signaling
is responsible for its pro-cell death role. Whether this is due to
direct cleavage of M1 chains and/or their indirect removal
through the previously demonstrated cleavage of K63 linkages
that are extended by linear chains remains to be determined.
Equally, whether removal of a specific M1 chain from a particular
target enables complex II formation, or multiple such events
together account for it, remains to be resolved.
A20 Binding to M1 Chains Inhibits Gene Activation
With respect to A20, we show that in absence of HOIP or M1-
ubiquitin A20 recruitment to SCs is almost completely prevented
and that genomic deletion of A20’s ZnF7, in turn, drastically
impairs recruitment. Thus, LUBAC, by placing M1 chains on
SC components, recruits A20 to these SCs via its ZnF7 (Fig-
ure 7H). These results are in line with the previous finding that
A20 can bind to M1-ubiquitin via its ZnF7 domain (Tokunaga
et al., 2012; Verhelst et al., 2012). Additionally, they provide thethors
Figure 7. A20 Stabilizes Linear Ubiquitination at the TNF-RSC and NOD2-SC
(A) A549 control or A20-KO cells were stimulated with TAP-TNF (500 ng/ml) for the indicated times, subjected to TNF-RSC purification and analyzed by
western blot.
(B) A549 cells pro- or deficient in A20 were virally transfected with NOD2-TAP and stimulated with L18-MDP (200 ng/ml) for the indicated times. The NOD2-SC
was isolated by a-Flag immunoprecipitation.
(legend continued on next page)
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biochemical explanation for the observation that TNF-RSC
recruitment of A20 lacking ZnF7was significantly reduced (Toku-
naga et al., 2012).
Even though A20 was shown to be incapable of cleaving M1
chains (Mevissen et al., 2013), we were surprised to find that
A20 significantly stabilized M1-ubiquitin in SCs. Given that
M1 chains are required for full gene-activatory signaling (Fiil
and Gyrd-Hansen, 2014; Iwai et al., 2014; Walczak et al.,
2012) and that A20 is a DUB previously described to inhibit
NF-kB signaling (Bosanac et al., 2010; Tokunaga et al., 2012;
Wertz et al., 2004), this finding seemed counterintuitive, at first.
Indeed, results obtained in reconstitution experiments showed
that it is ZnF7 and not A20’s enzymatic DUB activity or ZnF4
that is required for A20-mediated restriction of gene activation
(Skaug et al., 2011). Combined with our observation that ZnF7
is required for A20 recruitment to SCs due to its interaction with
LUBAC-generated M1 chains, which are, in turn, stabilized by
it, these findings now offer a possible alternative explanation
for A20’s NF-kB-inhibitory activity. A20 binding to M1 chains
in SCs could compete with the binding of other gene-activatory
factors, e.g., the NEMO/IKK complex, to them. Rising levels of
A20 protein, induced as a consequence of NF-kB activation,
would render M1 chains less available for NEMO/IKK retention
over time so that the negative feedback loop would be
completed.
A20 and CYLD Regulate Cell Death via Their Opposing
Activities on Linear Ubiquitin
A20 has also been implicated as a negative regulator of TNF-
induced cell death (Lee et al., 2000; Yamaguchi and Yamaguchi,
2015), whereas CYLD was shown to promote it (Hitomi et al.,
2008; O’Donnell et al., 2011). Thus, while they cooperatively
restrict gene activation from various SCs, they act in opposing
ways on TNF-induced cell death. Linear ubiquitination in the
TNF-RSC prevents TNF-induced cell death by restricting com-
plex II formation (Gerlach et al., 2011; Ikeda et al., 2011; Peltzer
et al., 2014). We show here that A20 binding to M1 chains in the
TNF-RSC stabilizes them, whereas CYLD antagonizes M1
chains in this complex. Together this implies that the ability of
A20 to bind M1 chains protects them from cleavage by DUBs
that are capable of cleaving linear ubiquitin chains in signaling
complexes. Having identified herein CYLD as a DUB with pre-
cisely this activity at the TNF-RSC, we therefore propose a
model according to which A20 protects M1 chains in the TNF-
RSC from CYLD-mediated cleavage, thereby providing the
sought after explanation for the opposing roles played by A20(C) A549 control cells or A549 cells lacking zinc finger 7 of A20 (A20-DZnF7) wer
(D–F) A20-deficient MEFs were reconstituted with A20-WT, A20-C103S, A20-Zn
subjected to TNF-RSCpurification (D). Cells were stimulatedwith TNF (200 ng/ml)
with TNF (200 ng/ml) in presence or absence of zVAD (20 mM) as indicated for 24 h
(data are presented as mean ± SEM [n = 3], *p < 0.05, statistics were performed
(G) Model of LUBAC regulation: (1) LUBAC is associated with OTULIN or CYLD
OTULIN leads to unregulated LUBAC activity, ultimately resulting in enhanced lin
(H) Model of CYLD and A20 recruitment to, and activity at, the TNF-RSC: (1) CYLD
in a HOIP-dependent manner. (2) At the SCs, CYLD antagonizes M1- and K63-li
prone to TNF-induced cell death. (3) A20 is recruited to the SC by its ZnF7 doma
(4) A20 binding to M1 chains prevents their removal and restricts gene-activatory
case of the TNF-RSC, renders cells more resistant to cell death induction from t
2270 Cell Reports 13, 2258–2272, December 15, 2015 ª2015 The Auand CYLD with regards to TNF-induced cell death. Intriguingly,
both roles depend on LUBAC-generated linear ubiquitin in the
TNF-RSC. Hence, an intricate interplay between LUBAC, linear
ubiquitination, A20, and CYLD is crucial for assembly and disas-
sembly of SCs to enable efficient, yet properly controlled,
immune signaling.
EXPERIMENTAL PROCEDURES
For description of cell lines, antibodies, and plasmids, see Supplemental
Experimental Procedures.
Recombinant Proteins
TAP-TNF, untagged TNF, recombinant deubiquitinases, and proteins used for
M1-AP, K63-AP, and Ubi-AP were produced in E. coli.
Generation of Knockout Cell Lines
HOIP- andHOIL-1-deficient K562 andHOIP-deficient A549 andHeLa cell lines
were prepared by transfecting mRNA encoding gene-specific zinc finger nu-
cleases (Sigma). CYLD-, OTULIN-, A20-deficient, and A20DZnF7-expressing
cells were prepared by lentiviral transduction with LentiCRISPR v2 vectors
(Sanjana et al., 2014) provided by Feng Zhang (Addgene plasmid #52961). Sin-
gle cell clones with protein knockout or control clones were verified by western
blotting.
Retroviral Transduction of Cells
Coding sequences of HOIP-WT, HOIP-C885S, HOIP-N102A, deletion mutants
of human HOIP fused or not at the C terminus to the TAP-tag and TAP-tagged
NOD2 (aa 28–1040) were inserted into the retroviral MSCV vector containing
GFP as selection marker. Upon infection, cells were sorted using MoFlo
FACS (Beckman Coulter).
Isolation of Ubiquitin Conjugates from Cell Lysates and
Deubiquitination Assay
Cells were lysed and proteins denatured in AP-lysis buffer containing 1%SDS.
Samples were subsequently diluted to 0.1% SDS before M1-, K63-, or total
ubiquitin-specific recombinant affinity protein coupled to HALO beads was
added for overnight incubation at 4C. Beads were washed, and samples
were subjected to treatment with 1 mM recombinant deubiquitinase for 1 hr
at 37C or eluted with reducing sample buffer.
Cell Stimulation and Immunoprecipitation
To analyze the native TNF-RSC, cells were treated with TAP-TNF as indicated.
Cells stably expressing NOD2-TAP were stimulated with L18-MDP. Cells
expressing TAP-tagged proteins were stimulated with untagged TNF. After
cell lysis, samples were subjected to anti-Flag immunoprecipitation using
M2 beads (Sigma) or incubated with protein A/G-Agarose beads (Santa Cruz
Biotechnology) coupled to indicated antibodies. For pervanadate treatment,
cells were incubated with 1 mM pervanadate for 20min before lysis. Phospha-
tase treatment was performed on lysates using 50U of FastAP (Thermo Scien-
tific) per mg of protein in absence of phosphatase inhibitors.e analyzed as in (A).
F7mut, or empty vector. Cells were stimulated with TAP-TNF (500 ng/ml) and
for the indicated times before analysis bywestern blot (E). Cells were stimulated
r, and cell death was evaluated as percentage of propidium iodide positive cells
using t test) (F).
in a mutually exclusive manner; (2) loss of LUBAC interaction with CYLD and
ear ubiquitination of LUBAC components themselves.
-associated LUBAC is recruited to the SC, thereby enabling CYLD recruitment
nked ubiquitination, thereby limiting gene activation and rendering cells more
in interacting with LUBAC-generated M1 linkages placed on SC components.
signaling, likely by competing with factors required for gene activation and, in
his SC.
thors
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